The Role of In Vitro Model Complexity in Lipid-Based Formulation Screening: A Case Study with Ticagrelor.

Bourderi-Cambon A, Fadhlaoui K, Rossano M, Chalancon S, Dhainaut C, Chevrier S, Schneider D, Denis S, Caisse P, Beyssac E

Open source

DOI
10.1021/acsomega.6c08404
Published
2026 Oct 6
Container
ACS omega
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1021/acsomega.6c08404,
  title = {The Role of In Vitro Model Complexity in Lipid-Based Formulation Screening: A Case Study with Ticagrelor.},
  author = {Bourderi-Cambon A and Fadhlaoui K and Rossano M and Chalancon S and Dhainaut C and Chevrier S and Schneider D and Denis S and Caisse P and Beyssac E},
  year = {2026},
  journal = {ACS omega},
  doi = {10.1021/acsomega.6c08404},
  url = {https://doi.org/10.1021/acsomega.6c08404}
}

RIS

TY  - JOUR
TI  - The Role of In Vitro Model Complexity in Lipid-Based Formulation Screening: A Case Study with Ticagrelor.
AU  - Bourderi-Cambon A
AU  - Fadhlaoui K
AU  - Rossano M
AU  - Chalancon S
AU  - Dhainaut C
AU  - Chevrier S
AU  - Schneider D
AU  - Denis S
AU  - Caisse P
AU  - Beyssac E
PY  - 2026
JO  - ACS omega
DO  - 10.1021/acsomega.6c08404
UR  - https://doi.org/10.1021/acsomega.6c08404
ER  - 

APA

A, B., K, F., M, R., S, C., C, D., S, C., D, S., S, D., P, C., & E, B. (2026). The Role of In Vitro Model Complexity in Lipid-Based Formulation Screening: A Case Study with Ticagrelor.. ACS omega. https://doi.org/10.1021/acsomega.6c08404

Source records